ARTICLE | Clinical News
M-Vax and O-Vax: Update
September 24, 2001 7:00 AM UTC
Avax Technologies Inc. (AVXT), Kansas City, Mo. Product: M-Vax and O-Vax Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Autologous tumor cell vaccines In...